{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:59:58Z","timestamp":1764277198805,"version":"3.40.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Cervical cancer screening plays a major role in preventing cervical cancer. The field is based on understanding the natural history of human papillomavirus and its role in cervical cancer. Screening has evolved to assessing the risk for cervical intraepithelial neoplasia grade 3, a true cancer precursor, and performing diagnostic tests based on those risks. This article summarizes the present state of management of abnormal cervical cancer screening tests in the United States, based on the most recent 2019 American Society of Colposcopy and Cervical Pathology guidelines.<\/jats:p>","DOI":"10.1097\/grf.0000000000000794","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T14:00:34Z","timestamp":1693490434000},"page":"478-499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Management of Abnormal Cervical Cancer Screening Test: A Risk-based Approach"],"prefix":"10.1097","volume":"66","author":[{"given":"Richard","family":"Guido","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital of the UPMC System, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca B.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine Chobanian & Avedisian School of Medicine, Boston Medical Center, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 Updated Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia\u2013grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/AOG.0000000000001721","article-title":"Similar risk patterns after cervical screening in two large U.S. populations: implications for clinical guidelines","volume":"128","author":"Gage","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R8-20250512","first-page":"01826","article-title":"Underscreenng, overscreening, and guideline-adherent cervical cancer screening in a national cohort","volume":"S0090-8258","author":"Lee","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jwh.2020.8918","article-title":"Summary of current guidelines for cervical cancer screening and management of abnormal test results: 2016-2020","volume":"30","author":"Perkins","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2014.55.9948","article-title":"Multiple biopsies and detection of cervical cancer precursors at colposcopy","volume":"33","author":"Wentzensen","year":"2015","journal-title":"J Clin Oncol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ijc.32950","article-title":"A study of the risks of CIN3+ detection after multiple rounds of HPV testing: results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California","volume":"147","author":"Hammer","year":"2020","journal-title":"Int J Cancer"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.10316","article-title":"Atypical glandular cells\u2014an update","volume":"29","author":"Cangiarella","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-0528.2010.02650.x","article-title":"Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials","volume":"117","author":"Castle","year":"2010","journal-title":"BJOG"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/dc.23955","article-title":"Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative","volume":"46","author":"Polanco Jacome","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/GMIT.GMIT_56_18","article-title":"Loop electrosurgical excision procedure versus cryotherapy in the treatment of cervical intraepithelialneoplasia: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"D\u2019Alessandro","year":"2018","journal-title":"Gynecol Minim Invasive Ther"},{"key":"R23-20250512","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003761","article-title":"Diagnosis and management of adenocarcinoma in situ: a Society of Gynecologic Oncology evidence-based review and recommendations","volume":"135","author":"Teoh","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction\u2014National Health and Nutrition Examination Survey, United States, 2003-2014","volume":"216","author":"Oliver","year":"2017","journal-title":"J Infect Dis"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-20-0846","article-title":"Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15-29 years in the United States, 1999-2017: an ecologic study","volume":"30","author":"Mix","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.15585\/mmwr.mm7135a1","article-title":"National vaccination coverage among adolescents aged 13-17 years\u2014National Immunization Survey-Teen, United States, 2021","volume":"71","author":"Pingali","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-17-0293","article-title":"Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years","volume":"11","author":"Silver","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"R34-20250512","first-page":"01009","article-title":"Cost-effectiveness analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"S0002-9378","author":"Munshi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/LGT.0000000000000336","article-title":"ASCCP colposcopy standards: how do we perform colposcopy? Implications fOR ESTABLISHING STANDards","volume":"21","author":"Waxman","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0000000000000338","article-title":"ASCCP Colposcopy Standards: role of colposcopy, benefits, potential harms, and terminology for colposcopic practice","volume":"21","author":"Khan","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/LGT.0000000000000322","article-title":"Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States","volume":"21","author":"Wentzensen","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/LGT.0000000000000334","article-title":"ASCCP Colposcopy Standards: risk-based colposcopy practice","volume":"21","author":"Wentzensen","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0029-7844(97)00470-5","article-title":"A randomized controlled trial to evaluate the use of the endocervical brush after endocervical curettage","volume":"90","author":"Tate","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R41-20250512","first-page":"97","article-title":"Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy","volume":"27","author":"Massad","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/jwh.2022.0100","article-title":"Computable guidelines and clinical decision support for cervical cancer screening and management to improve outcomes and health equity","volume":"31","author":"Saraiya","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2020.12488","article-title":"Managing minimally abnormal cervical cancer screening test results","volume":"324","author":"Sawaya","year":"2020","journal-title":"JAMA"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamainternmed.2019.0306","article-title":"Clinical evaluation of human papillomavirus screening with p16\/Ki-67 dual stain triage in a large organized cervical cancer screening program","volume":"179","author":"Wentzensen","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R47-20250512","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.33812","article-title":"Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: results from the IMPACT trial","volume":"150","author":"Wright","year":"2022","journal-title":"Int J Cancer"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:14:09Z","timestamp":1747062849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000794","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}